van Meyel J J, Smits P, Gribnau F W
Department of Pharmacology and Clinical Pharmacology, University of Nijmegen, The Netherlands.
Br J Clin Pharmacol. 1990 Nov;30(5):774-7. doi: 10.1111/j.1365-2125.1990.tb03849.x.
In a study of cross-over randomized design in 12 healthy volunteers we compared the effect on magnesium excretion after administration of single oral doses of frusemide 40 mg (F) and of frusemide 40 mg in combination with a single dose of triamterene 50 mg (F+T). F as well as F+T induced significant increases in volume, sodium and magnesium mean 24 h output as compared with 24 h renal excretion without medication. Addition of triamterene to frusemide significantly reduced the 24 h potassium excretion, but did not attenuate the excretion of magnesium. The time to reach the maximum magnesium excretion rate after F as well as after F+T administration was similar to that of the sodium excretion rate. We conclude that triamterene does not inhibit the magnesiuric effects of frusemide in healthy male adults.
在一项针对12名健康志愿者的交叉随机设计研究中,我们比较了单次口服40毫克速尿(F)以及40毫克速尿与单次50毫克氨苯蝶啶联合使用(F + T)后对镁排泄的影响。与未用药时的24小时肾脏排泄相比,F以及F + T均导致尿量、钠和镁的24小时平均排出量显著增加。在速尿中添加氨苯蝶啶可显著减少24小时钾排泄,但并未减弱镁的排泄。F以及F + T给药后达到最大镁排泄率的时间与钠排泄率的时间相似。我们得出结论,在健康成年男性中,氨苯蝶啶不会抑制速尿的排镁作用。